Cargando…
P1128: CLINICAL FEATURES AND OUTCOME OF PATIENTS WITH CASTLEMAN DISEASE: A SPANISH MULTICENTRIC STUDY OF 134 PATIENTS FROM GELTAMO
Autores principales: | Navarro, J. T., Celades, C., García, O., González-Barca, E., Climent, F., Feu, A., Jiménez, A., Gutiérrez de la Peña, A., Bastos-Oreiro, M., Aldamiz-Echevarria, T., Gutiérrez, A., Bento, L., Abrisqueta, P., Alonso, C. M., Tejada Chavez, C., Ocio, E. M., Fernández Escalada, N., Navarro Matilla, M. B., Mateos Pérez, J. M., López-García, A., Castillo-Girón, C., Pinzón, S. F., Pérez Ceballos, E., Hernández Rivas, J. Á., del Campo García, R., Pardal de la Mano, E., García-Sanz, R., Rovira, J., Sancho, J. M., Tapia, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430203/ http://dx.doi.org/10.1097/01.HS9.0000847380.18966.c6 |
Ejemplares similares
-
P1083: BRENTUXIMAB VEDOTIN, ETOPOSIDE, SOLUMEDROL, HIGH DOSE ARA-C & PLATINUM FOLLOWED BY HDT & APBSCT FOR REFRACTORY/RELAPSED HODGKIN LYMPHOMA PATIENTS: LONG-TERM RESULTS OF THE GELTAMO GROUP BRESHAP STUDY
por: Garcia-Sanz, R., et al.
Publicado: (2022) -
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups
por: Bastos-Oreiro, Mariana, et al.
Publicado: (2022) -
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
por: García-Sancho, Alejandro Martín, et al.
Publicado: (2022) -
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups
por: Rey-Búa, Beatriz, et al.
Publicado: (2022) -
Castleman's Disease: A Case Report of the Unicentric Type
por: Gomez-Ramirez, J., et al.
Publicado: (2012)